Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Explore the Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Adult Male Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 22 May 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Oliceridine (Primary) ; Morphine
Indications Pain
Focus Proof of concept; Therapeutic Use
Sponsors Trevena

Most Recent Events

15 May 2023 According to a Trevena media release, topline data expected in 3Q 2023 from this proof of concept study supporting continued development for potential use in chronic pain.
01 Sep 2020 Data were used for population pharmacokinetic-pharmacodynamic analysis from this trial published in the Anesthesiology
26 Aug 2020 Results from a pooled analysis of this trial presented in a Trevena Media Release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com